Befidi Robert has filed 16 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 7605 shares of Envista Holdings Corp ($NVST) on February 25, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Common Stock | 7605 | $0.00 | 50,932.0000 | 169,200,000 | 17.55% | 0.00% |
| Feb. 25, 2026 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | F | Common Stock | 2177 | $29.59 | 43,327.0000 | 169,200,000 | 4.78% | 0.00% |
| Feb. 25, 2026 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 18020 | $0.00 | 18,020.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2026 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 13845 | $0.00 | 13,845.0000 | 169,200,000 | 9999.99% | 0.01% |
| Feb. 1, 2026 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Envista deferred contribution programs - Envista Stock Fund | 998 | $23.47 | 2,149.0000 | 169,200,000 | 86.71% | 0.00% |
| Aug. 25, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | F | Common Stock | 3454 | $21.12 | 45,504.0000 | 172,200,000 | 7.06% | 0.00% |
| Feb. 25, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | F | Common Stock | 1123 | $20.66 | 38,668.0000 | 172,200,000 | 2.82% | 0.00% |
| Feb. 25, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Common Stock | 10290 | $0.00 | 48,958.0000 | 172,200,000 | 26.61% | 0.01% |
| Feb. 25, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 18960 | $0.00 | 18,960.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 24010 | $0.00 | 24,010.0000 | 172,200,000 | 9999.99% | 0.01% |
| Feb. 1, 2025 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Envista deferred contribution programs - Envista Stock Fund | 1151 | $20.52 | 1,151.0000 | 172,200,000 | 9999.99% | 0.00% |
| Aug. 25, 2024 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Performance Option | 70400 | $0.00 | 70,400.0000 | 166,900,000 | 9999.99% | 0.04% |
| Aug. 25, 2024 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | F | Common Stock | 3454 | $18.70 | 39,791.0000 | 166,900,000 | 7.99% | 0.00% |
| Feb. 25, 2024 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Employee Stock Option (Right to Buy) | 21910 | $0.00 | 21,910.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Performance Share Unit | 17260 | $0.00 | 17,260.0000 | 166,900,000 | 9999.99% | 0.01% |
| Feb. 25, 2024 | Envista Holdings Corp | $NVST | Befidi Robert | President, Diagnostics | A | Common Stock | 9385 | $0.00 | 43,245.0000 | 166,900,000 | 27.72% | 0.01% |